STAGE IIA RECTAL CANCER AJCC V8
Clinical trials for STAGE IIA RECTAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA RECTAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIA RECTAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink rectal tumors with fewer side effects
Disease control OngoingThis early-stage study tests the safety of combining the chemotherapy drug TAS-102 with standard radiation for people with stage II or III rectal cancer that hasn't spread. The goal is to find the best dose that kills tumor cells while limiting side effects, before surgery to rem…
Matched conditions: STAGE IIA RECTAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 17, 2026 03:08 UTC
-
The hidden cost of beating cancer: new study tracks financial toll on patients
Knowledge-focused OngoingThis study follows 565 people with stage I-III colon or rectal cancer who are being treated with the goal of a cure. Researchers track how treatment affects patients' finances and quality of life over 12 months. The goal is to help doctors understand the financial burden of cance…
Matched conditions: STAGE IIA RECTAL CANCER AJCC V8
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated May 17, 2026 03:18 UTC